Patton Fund Management’s Quest Diagnostics DGX Stock Holding History

Patton Fund Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.58M	Sell	7,459 -4,314	-37%	-$847K	0.34%	81
2026 Q1	$2.31M	Sell	11,773 -20,266	-63%	-$3.94M	0.39%	89
2025 Q4	$5.56M	Buy	32,039 +30,772	+2,429%	+$5.6M	0.75%	61
2025 Q3	$241K	Hold	1,267	–	–	0.04%	303
2025 Q2	$228K	Buy	+1,267	New	+$220K	0.05%	327
2023 Q1	–	Sell	-1,309	Closed	-$205K	–	124
2022 Q4	$205K	Buy	+1,309	New	+$188K	0.06%	165
2020 Q4	–	Sell	-7,473	Closed	-$856K	–	80
2020 Q3	$856K	Sell	7,473 -360	-5%	-$42.5K	0.46%	71
2020 Q2	$893K	Buy	+7,833	New	+$831K	0.52%	58

Other funds holding DGX

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

SIC

Schwartz Investment Counsel Plymouth, Michigan $3.01B AUM 27.22% 1-Year Est. Return

BCAM

Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return

Patton Fund Management's DGX Position: Q2 2026 in Review

Patton Fund Management reduced its Quest Diagnostics (DGX) stake by 37% in Q2 2026, selling an estimated $847K and leaving 7,459 shares worth $1.58M. The position accounts for 0.34% of the portfolio, ranked #81.

Patton Fund Management first reported a position in DGX in Q2 2020 and has held it in 8 quarters since. The position peaked at $5.56M in Q4 2025. 351 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Patton Fund Management held 7,459 shares of Quest Diagnostics worth $1.58M as of Q2 2026.
Patton Fund Management sold 4,314 Quest Diagnostics shares in Q2 2026, an estimated $847K.
Quest Diagnostics made up 0.34% of Patton Fund Management's portfolio in Q2 2026, its #81 holding.
Patton Fund Management first reported a position in Quest Diagnostics in Q2 2020 and has held it in 8 quarters since.
Patton Fund Management's Quest Diagnostics position peaked at $5.56M in Q4 2025.
351 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Patton Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.